Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

337 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Is levodopa toxic?
Müller T, Hefter H, Hueber R, Jost WH, Leenders KL, Odin P, Schwarz J. Müller T, et al. Among authors: jost wh. J Neurol. 2004 Sep;251 Suppl 6:VI/44-6. doi: 10.1007/s00415-004-1610-x. J Neurol. 2004. PMID: 15675725 Review.
Initial experience with ropinirole PR (prolonged release).
Jost WH, Buhmann C, Fuchs G, Greulich W, Hummel S, Korchounov A, Müngersdorf M, Schwarz M, Spiegel-Meixensberger M. Jost WH, et al. J Neurol. 2008 Sep;255 Suppl 5:60-3. doi: 10.1007/s00415-008-5008-z. J Neurol. 2008. PMID: 18787884 Review.
[When should we start medical treatment in Parkinson disease].
Buhmann C, Klucken J, Korchounov A, Schwarz M, Vieregge P, Jost WH. Buhmann C, et al. Among authors: jost wh. Fortschr Neurol Psychiatr. 2010 Mar;78 Suppl 1:S31-3. doi: 10.1055/s-0029-1245169. Epub 2010 Mar 1. Fortschr Neurol Psychiatr. 2010. PMID: 20195939 Review. German.
Depression in Parkinson's disease.
Schwarz J, Odin P, Buhmann C, Csoti I, Jost W, Wüllner U, Storch A. Schwarz J, et al. J Neurol. 2011 May;258(Suppl 2):S336-8. doi: 10.1007/s00415-011-6048-3. J Neurol. 2011. PMID: 21560065 Review.
Influence of the nonergot dopamine agonist piribedil on vigilance in patients With Parkinson Disease and excessive daytime sleepiness (PiViCog-PD): an 11-week randomized comparison trial against pramipexole and ropinirole.
Eggert K, Öhlwein C, Kassubek J, Wolz M, Kupsch A, Ceballos-Baumann A, Ehret R, Polzer U, Klostermann F, Schwarz J, Fuchs G, Jost W, Albert A, Haag A, Hermsen A, Lohmüller K, Kuhn K, Wangemann M, Oertel WH; In Cooperation With the German Competence Network on Parkinson’s Disease. Eggert K, et al. Among authors: jost w. Clin Neuropharmacol. 2014 Jul-Aug;37(4):116-22. doi: 10.1097/WNF.0000000000000041. Clin Neuropharmacol. 2014. PMID: 24992083 Clinical Trial.
Quantitative assessment of non-motor fluctuations in Parkinson's disease using the Non-Motor Symptoms Scale (NMSS).
Storch A, Schneider CB, Klingelhöfer L, Odin P, Fuchs G, Jost WH, Martinez-Martin P, Koch R, Reichmann H, Chaudhuri KR; NoMoFlu-PD study group; Ebersbach G. Storch A, et al. Among authors: jost wh. J Neural Transm (Vienna). 2015 Dec;122(12):1673-84. doi: 10.1007/s00702-015-1437-x. Epub 2015 Aug 12. J Neural Transm (Vienna). 2015. PMID: 26264174
337 results